Nuritas raises €16m in Series A funding

21 Dec 2017 --- Nuritas has announced the close of a circa €16 million (US$19 million) Series A funding round led by Chicago-based Cultivian Sandbox Ventures. This brings the total invested to date to approximately €25 million, the company reports. The latest round of funding will support Nuritas’ global growth to address and solve many of the most pressing health issues of the day, including the diabetes epidemic. 

Nutrition industry “feels positive” about new EU rules for novel foods: survey

19 Dec 2017 --- According to research by the organizers of Vitafoods Europe, many people working in the nutrition industry feel positive about the EU’s new process for the approval of novel foods. However, experts are warning that there could be adverse implications for some companies’ intellectual property portfolios. The new regulations on novel foods, defined as anything without a significant history of consumption in the EU before 15 May 1997, come into force on 1 January 2018. For the first time, the approval system will be centralized, with applications submitted to the European Commission rather than individual member states.

Seventure Partners’ microbiome portfolio nears critical milestones 

18 Dec 2017 --- Seventure Partners, one of Europe’s leaders in financing innovation, and a world-leader in the venture investment in the microbiome sector, is seeing rapid progress from innovation into human trials, with five of its portfolio companies advancing their human microbiome products with varying modalities and therapeutics targets in clinical trials.

Enzymotec and Frutarom merger gets shareholder green light

12 Dec 2017 --- The shareholders of Israeli specialty chemicals company Enzymotec Ltd. have approved by large majority the merger transaction between Frutarom and Enzymotec. The transaction was approved at Enzymotec’s General Meeting by 99.9 percent majority of shareholders present at the meeting and entitled to vote, Frutarom Industries Ltd. reports.

Cardiovascular risk in diabetes can be reduced using hormones, claims study

04 Dec 2017 --- Scientists at Joslin Diabetes Center in the US have taken another step toward solving a long-standing puzzle about heart health in Type 2 diabetes, with a finding that eventually may point towards more personalized patient care. Genetic analysis has linked the hormone known as glucagon-like peptide 1 (GLP-1) with cardiovascular mortality risks.

BASF plant fire: Force Majeure for vitamins and carotenoids at Citral plant

10 Nov 2017 --- BASF has announced that it has shut down its Citral plant in Ludwigshafen, Germany, and has had to declare Force Majeure for its Citral- and Isoprenol-based aroma ingredients following a fire on October 31 during the startup of the plant.

New MenaQ7 patents granted to NattoPharma in US, Israel and Australia

08 Nov 2017 --- NattoPharma ASA has successfully secured patents in Israel, the US and Australia for its “nature-identical synthesis” creating MenaQ7 PharmaPure Vitamin K2 as MK-7, adding further to the company’s patent portfolio.

BASF to enter US medical foods market with product to manage NAFLD

06 Nov 2017 --- BASF and DIEM Labs have entered into a distribution agreement to commercialize BASF’s first US medical food product for the dietary management of patients with non-alcoholic fatty liver disease (NAFLD). As part of this agreement, BASF has announced that it will use its scientific expertise and state-of-the-art manufacturing capabilities to provide a first-to-the-market medical food product to patients with NAFLD. 

Oils and more: Neptune explores new frontiers in cannabis space

06 Nov 2017 --- Thanks to the complex regulatory situations surrounding the ingredient in various countries around the world, cannabis products currently do not have a clear roadmap for success. However, this doesn’t mean that there are not opportunities in the space. One company currently making a mark in the industry is Neptune Wellness Solutions.

Chr. Hansen: 10 percent organic growth for 2016/2017

25 Oct 2017 --- Chr. Hansen has announced its 2016/2017 Q4 results, with revenue reaching €283 million (US$333 million), compared to €256 million in Q4 2015/2016, corresponding to organic growth of 12 percent. Organic growth for the year as a whole reached 10 percent, and the EBIT margin before special items ended at 28.9 percent, up from 28.2 percent the year before.

Neptune chief eyes strong potential for new cannabis business as executive appointments installed

05 Oct 2017 --- Wellness products company Neptune Wellness Solutions has appointed Michel Timperio as President of its new Cannabis Business and Melody Harwood as Head of Scientific and Regulatory Affairs. Timperio will report to Jim Hamilton, President and CEO of Neptune. 

Three cups of coffee found to halve mortality risk in patients with both HIV and HCV

26 Sep 2017 --- Further potential benefits of drinking coffee have emerged with the news that in HIV-HCV co-infected patients, drinking at least three cups of coffee each day halved the risk of all-cause mortality. This is according to a new study published in the Journal of Hepatology.

Cutting calories now “critical” to UK childhood obesity strategy

18 Aug 2017 --- The health agency Public Health England (PHE) has shifted its focus away from solely targeting sugar to cutting excess calorie consumption from all sources in its anti-obesity strategy for children in the UK. “A third of children leave primary school overweight or obese and an excess of calories – not just excess sugar consumption – is the root cause of this,” says Duncan Selbie, Chief Executive of PHE. “We will work with the food companies and retailers to tackle this as the next critical step in combating our childhood obesity problem.”

Looking to the future of antioxidants

16 Aug 2017 --- As antioxidants maintain their popularity, companies that produce them are continually looking to future potential applications. Today, NutritionInsight concludes its special report by looking at the research that has been conducted into future opportunities for their use and ingredients that might be popular in the future. You can read the first part of our report here.

App to improve low-income diets designed by US students

14 Aug 2017 --- A team of US students at Stanford Biodesign is developing an app that aims to help low-income Californians improve their diets, the university has announced. The team, which came together during the “Biodesign for mobile health” course last fall, took advantage of a new program, called Biodesign NEXT, which provides mentorship, funding, and academic credit to allow students to keep working on promising projects after the 10-week academic quarter ends.

Astaxanthin could reduce skin aging, finds AstaReal study

14 Aug 2017 --- Astaxanthin from the AstaReal Group has demonstrable benefits for the skin, according to a combined in vitro and in vivo clinical study sponsored by parent company Fuji Chemical Industries Co, Ltd. The company, which specializes in the naturally occurring carotenoid astaxanthin, reports that a cell assay was performed to analyze effects of astaxanthin on skin cells (epidermal keratinocytes) when exposed to UV-B irradiation.

Human and pet supplements consolidated under Stratum Nutrition brand

02 Aug 2017 --- ESM Technologies, LLC (ESM) has announced that it has consolidated its human and pet supplement ingredients business under the Stratum Nutrition brand. The news comes as ESM acquires the Stratum Nutrition brand and related assets from Novus Nutrition Brands, LLC (NNB), ESM’s majority member. This transition commenced on April 1, 2017.

Naturex robust revenues driven by plant-based, natural trends

01 Aug 2017 --- Plant-based, natural ingredients specialist, Naturex, has announced its 2017 second quarter results and first half revenue, which shows a steady performance that is “on track” with the company’s strategy. Consolidated revenue for the first half of the year amounted to €207.5 million (US$245 million), largely stable over the two-quarters, compared to the high base for the same period in 2016. Like-for-like revenue contracted marginally 1.9 percent.

Soda’s popularity on kids’ menus beginning to fizz out

25 Jul 2017 --- The percentage of major restaurant chains that offer sugary drinks on their children’s menus has decreased from 93 percent to 74 percent since 2008, according to a new report by the Center for Science in the Public Interest (CSPI). But the consumer lobby group warns that despite the significant decrease, chains owe it to families to improve their children’s beverages even further.

Chr. Hansen “Stronger Than Expected” in Q3 with Nutrition Showing Robust Growth

05 Jul 2017 --- Danish food ingredients giant Chr. Hansen has seen strong organic revenue growth of 10 percent in the first nine months of 2016/17 and thanks to the robust performance has announced the payment of an interim dividend. Based on the company’s strong performance, it has narrowed its organic revenue expectations for 2016/17 to between 9 and 10 percent from previously 8 to 10 percent.

loading